Skip to Main content Skip to Navigation
Poster communications

Pre-clinical animal models and targeted therapies on cognition: Direct Impact of the PI3K inhibitor buparlisib

Martine Dubois 1, 2 Marie-Christine Tonon 1, 2 Nicolas Perzo 3, 2 Pierrick Gandolfo 1, 2 Pascal Hilber 4 Florence Joly 5 Hélène Castel 1, 2 
1 DC2N - Différenciation et communication neuronale et neuroendocrine
2 DC2N - Différenciation et communication neuronale et neuroendocrine
3 UdeS - Université de Sherbrooke
4 PSY-NCA - Psychologie et Neurosciences de la Cognition et de l'affectivité
5 Service d'Oncologie médicale [CHU Caen]
Document type :
Poster communications
Complete list of metadata
https://hal-normandie-univ.archives-ouvertes.fr/hal-02351458
Contributor : Hélène CASTEL Connect in order to contact the contributor
Submitted on : Wednesday, November 6, 2019 - 2:03:05 PM
Last modification on : Wednesday, March 2, 2022 - 3:48:02 PM

Identifiers

  • HAL Id : hal-02351458, version 1

Collections

COMUE-NORMANDIE | UNIROUEN | DC2N

Citation

Martine Dubois, Marie-Christine Tonon, Nicolas Perzo, Pierrick Gandolfo, Pascal Hilber, et al.. Pre-clinical animal models and targeted therapies on cognition: Direct Impact of the PI3K inhibitor buparlisib. 19th Annual meeting of the LARC-Neuroscience network, Nov 2015, Amiens, France. ⟨hal-02351458⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

16